Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.

BACKGROUND AND PURPOSE: Neoadjuvant chemoradiation could improve survival in patients with pancreatic cancer because of a higher rate of R0 resections, lower rate of nodal metastasis (ypN) and of local recurrence. This approach was tested in a cohort to estimate its effect on survival. PATIENTS AND...

Full description

Bibliographic Details
Main Authors:	Tinkl, D, Grabenbauer, G, Golcher, H, Meyer, T, Papadopoulos, T, Hohenberger, W, Sauer, R, Brunner, T
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
by: Golcher, H, et al.
Published: (2008)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon?
by: Fokas, E, et al.
Published: (2015)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?
by: Fokas, E, et al.
Published: (2015)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
by: Brunner, T, et al.
Published: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
by: Brunner, T, et al.
Published: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
by: Brunner, T, et al.
Published: (2008)

PREOPERATIVE CHEMORADIATION FOR RESECTABLE ADENOCARCINOMA OF THE PANCREAS (ISRCTN 78805636): PATTERN OF RECURRENCE.
by: Golcher, H, et al.
Published: (2012)

Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
by: Brunner, T, et al.
Published: (2008)

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma.
by: Mantoni, T, et al.
Published: (2008)

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma
by: Mantoni, T, et al.
Published: (2008)

Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
by: MacGregor, T, et al.
Published: (2012)

Predicting Respiratory Motion for Patients Undergoing Pancreatic Chemoradiation in the Absence of Volumetric Motion Imaging
by: Eccles, C, et al.
Published: (2010)

Predicting Respiratory Motion for Patients Undergoing Pancreatic Chemoradiation in the Absence of Volumetric Motion Imaging
by: Eccles, C, et al.
Published: (2010)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
by: Crosby, T, et al.
Published: (2004)

Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer
by: Browning, RJ, et al.
Published: (2021)

The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
by: Brunner, T, et al.
Published: (2010)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
by: Fokas, E, et al.
Published: (2013)

Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
by: Meier, I, et al.
Published: (2008)

[The role of radiochemotherapy in multimodal therapy of pancreatic cancer].
by: Brunner, T, et al.
Published: (2007)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
by: Millo, J, et al.
Published: (2003)

Molecular radiosensitization of pancreatic carcinoma cell lines in vivo and in vitro
by: Cengel, K, et al.
Published: (2004)

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
by: Lim, L.Y., et al.
Published: (2016)

The impact of histological variants of urothelial carcinoma on clinical outcomes following trimodality bladder-sparing chemoradiation
by: Kiltie, A, et al.
Published: (2017)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
by: Witztum, A, et al.
Published: (2016)

Study of preoperative focused microwave phased array thermotherapy in combination with neoadjuvant anthracycline-based chemotherapy for large breast carcinomas
by: Vargas, H.I., et al.
Published: (2023)

Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
by: Gasparini, G, et al.
Published: (1995)

A comparison of four target volume definitions for pancreatic cancer: Two concepts including the lymphatics (RTOG and German multi-centre neoadjuvant trial) and two concepts only treating the primary tumour (Michigan and UK-SCALOP)
by: Fokas, E, et al.
Published: (2012)

Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.
by: Gordon-Weeks, A, et al.
Published: (2011)

Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria
by: Gordon-Weeks, A, et al.
Published: (2011)

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.
by: Brunner, T, et al.
Published: (2011)

Knockdown of the integral membrane protein caveolin-1 sensitizes human pancreatic carcinoma cells to ionizing radiation
by: Cordes, N, et al.
Published: (2008)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
by: Findlay, J, et al.
Published: (2017)

Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study
by: Lee, D, et al.
Published: (2024)

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
by: Wilson, J, et al.
Published: (2016)

Radiotherapy in pancreatic cancer.
by: Klautke, G, et al.
Published: (2008)

Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
by: Fokas, E, et al.
Published: (2014)

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder
by: Blick, C, et al.
Published: (2012)

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
by: Blick, C, et al.
Published: (2012)